Skip to main content

Vivo Opportunity, LLC

In the past year, 3 open-market purchase filings worth $433.5K and no sales.

Current role at each company

Show 1 more company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
$433.5K
3 filings
Sold
–
0 filings
Net
+$433.5K
Bought minus sold
Companies
1
With open-market trades

Trades

Every Form 4 that lists Vivo Opportunity, LLC as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

INM InMed Pharmaceuticals Inc.

10% Owner3 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jul 16, 2026 (view filing)9:58 PM ETJul 14-162 daysVivo Opportunity, LLC and 3 others10% OwnerPPurchase+20.5K$1.55+$31.8K+37.7%75.0K after6 lots
Jul 2, 2026 (view filing)7:02 PM ETJun 30-Jul 22 daysVivo Opportunity, LLC and 3 others10% OwnerPPurchase+6.55K$1.55+$10.1K+9.8%73.1K after6 lots
Jun 10, 2026 (view filing)9:14 PM ETMay 20-Jun 821 daysLateVivo Opportunity, LLC and 3 others10% OwnerPPurchase+249.2K$1.57+$391.6KNew position72.5K after18 lots

SLNO Soleno Therapeutics Inc

10% Owner3 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Mar 28, 2025 (view filing)7:03 PM ETMar 26-282 daysVivo Opportunity, LLC and 1 other10% OwnerSSale−1.83M$67.87−$124.4M−29.1%4.46M after3 lots
Aug 29, 2024 (view filing)7:36 PM ETAug 27-292 daysVivo Opportunity, LLC and 1 other10% OwnerSSale−1.02M$48.01−$49.2M−14.0%6.29M after3 lots
May 1, 2024 (view filing)1:10 PM ETApr 29-302 daysVivo Opportunity, LLC and 1 other10% OwnerSSale−1.10M$46.95−$51.7M−13.1%7.32M after2 lots

TERN Terns Pharmaceuticals, Inc.

10% Owner5 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Apr 3, 2024 (view filing)8:47 PM ETApr 1-32 daysVivo Capital Fund VIII, L.P. and 4 others10% OwnerSSale−420.7K$6.65−$2.80M−61.0%268.6K after9 lots10b5-1
Dec 23, 2022 (view filing)5:48 PM ETDec 23Same dayVivo Capital Fund VIII, L.P. and 4 others10% OwnerPPurchase+758.6K$7.25+$5.50M+21.2%4.34M afterDuplicate filing
Sep 8, 2022 (view filing)8:00 PM ETSep 71 dayVivo Capital Fund VIII, L.P. and 4 others10% OwnerPPurchase+600.0K$3.60+$2.16M+20.1%3.58M afterDuplicate filing
Aug 16, 2022 (view filing)8:44 PM ETAug 12-164 daysVivo Capital Fund VIII, L.P. and 4 others10% OwnerPPurchase+2.62M$2.66+$6.98M+734.4%2.98M after3 lotsDuplicate filing
Aug 16, 2022 (view filing)8:44 PM ETAug 16Same dayVivo Capital Fund VIII, L.P. and 4 others10% OwnerPPurchase+1.50M$2.42+$3.63M–1.50M afterDerivative

BOLT Bolt Biotherapeutics, Inc.

10% Owner3 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Nov 22, 2023 (view filing)6:51 PM ETNov 211 dayVivo Capital Fund VIII, L.P. and 6 others10% OwnerSSale−3.40K$0.90−$3.06K−3.0%111.7K after3 lots
Nov 20, 2023 (view filing)9:09 PM ETNov 16-204 daysVivo Capital Fund VIII, L.P. and 6 others10% OwnerSSale−77.8K$0.9288−$72.3K−40.8%113.1K after8 lots
Nov 20, 2023 (view filing)9:09 PM ETNov 173 daysVivo Capital Fund VIII, L.P. and 6 others10% OwnerSSaleComon Stock−8.21K$0.93−$7.64K−0.4%1.98M after

IOBT IO Biotech, Inc.

10% Owner2 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Aug 10, 2023 (view filing)9:03 AM ETAug 91 dayVivo Opportunity, LLC and 3 others10% OwnerPPurchase+3.16M$1.90+$6.00MNew position3.16M after
Aug 10, 2023 (view filing)9:03 AM ETAug 91 dayVivo Opportunity, LLC and 3 others10% OwnerPPurchase+3.16M$0.125+$394.7K–3.16M afterDerivative

SRRA Sierra Oncology, Inc.

Director, 10% Owner1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jan 31, 2022 (view filing)9:30 PM ETJan 31Same dayVivo Ventures Fund VII, L.P. and 6 others10% OwnerPPurchase+800.0K$27.00+$21.6M+41.3%2.74M afterDuplicate filing